The Novel Protein Suppressed in Lung Cancer Down-Regulated in Lung Cancer Tissues Retards Cell Proliferation and Inhibits the Oncokinase Aurora-A

NCUIR > college of Health Sciences and Technology > Institute of Systems Biology and Bioinformatics > journal & Dissertation > Item 987654321/51088

Please use this identifier to cite or link to this item: http://ir.lib.ncu.edu.tw/handle/987654321/51088

Title:	The Novel Protein Suppressed in Lung Cancer Down-Regulated in Lung Cancer Tissues Retards Cell Proliferation and Inhibits the Oncokinase Aurora-A
Authors:	Yu,CTR;Hsia,JY;Hseih,YC;Su,LJ;Lee,TC;Ku,CF;Chen,KS;Chen,JMM;Wei,TYW;Lee,YCG;Huang,CYF;Wu,YC;Yang,CY;Hsu,SL
Contributors:	系統生物與生物資訊研究所
Keywords:	KINASE INHIBITORS;CARCINOMA MODEL;GENE-MUTATIONS;EXPRESSION;SELENOCYSTEINE;EPIDEMIOLOGY;THERAPY;TARGETS;MITOSIS;MATRIX
Date:	2011
Issue Date:	2012-03-27 18:21:03 (UTC+8)
Publisher:	國立中央大學
Abstract:	Introduction: In an attempt to search for genes with abnormal expression in cancers, Suppressed in Lung Cancer (SLAN, also known as KIAA0256) is found underexpressed in human lung cancer tissues by quantitative real-time PCR (Q-RT-PCR). The study set out to characterize SLAN protein and explore its cellular functions. Methods: SLAN or its specific short hairpin RNA, full length or various deletion mutants were overexpressed in 293T or lung cancer cell lines, and cell proliferation, cell cycle, mitosis progression, and spindle configuration were surveyed. Results: SLAN and its deletion mutants are localized to many subcellular locations such as endoplasmic reticulum (ER), nucleus, nucleolus, spindle pole and midbody, suggesting SLAN may function as a multifunctional protein. Overexpression of SLAN per se or its short hairpin RNAs (shRNAs) inhibits or accelerates cell proliferation through prolonging or shortening mitosis. Time-lapse microscopic recording reveals that cells overexpressing exogenous SLAN are arrested in mitosis or cannot undergo cytokinesis. SLAN 2-551 mutants drastically arrest cells in mitosis, where alpha- and gamma-tubulin are disorganized. SLAN employs C-terminal to interact with Aurora-A, a key mitosis regulator and an oncogenic kinase associated with a wide range of human cancers. SLAN negatively regulates the activity of Aurora-A by directly inhibiting kinase activity in vitro or reducing the level of active Aurora-A in cells. SLAN is frequently reduced in lung cancer tissues overexpressing Aurora-A, arguing for the necessity to suppress SLAN during the Aurora-A-associated cancer formation. Conclusions: Taken together, we have identified a novel protein SLAN downregulated in lung caner, having multiple subcellular localization including spindle matrix and midbody, inhibiting cell proliferation and Aurora-A.
Relation:	JOURNAL OF THORACIC ONCOLOGY
Appears in Collections:	[Institute of Systems Biology and Bioinformatics] journal & Dissertation

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	729	View/Open

社群 sharing

Loading...